• Markets
• News
• Learn

Gainers

• Bluejay Diagnostics (NASDAQ:BJDX) stock increased by 165.7% to $9.38 during Monday's pre-market session. The company's market cap stands at $5.1 million.
• Gyre Therapeutics (NASDAQ:GYRE) stock increased by 37.28% to $9.5. The market value of their outstanding shares is at $889.3 million.
• Tharimmune (NASDAQ:THAR) shares moved upwards by 35.31% to $1.59. The market value of their outstanding shares is at $3.0 million.
• Molecular Partners (NASDAQ:MOLN) stock rose 26.07% to $4.5. The market value of their outstanding shares is at $165.9 million.
• Cue Biopharma (NASDAQ:CUE) stock moved upwards by 19.98% to $0.81. The company's market cap stands at $51.3 million.
• I-MAB (NASDAQ:IMAB) shares increased by 18.63% to $0.81. The company's market cap stands at $65.2 million. As per the press release, FY earnings came out 2 days ago.

Losers

• Quoin Pharmaceuticals (NASDAQ:QNRX) stock fell 37.0% to $0.15 during Monday's pre-market session. The company's market cap stands at $3.0 million.
• CeriBell (NASDAQ:CBLL) shares decreased by 29.45% to $13.01. The market value of their outstanding shares is at $466.6 million.
• Bioventus (NASDAQ:BVS) stock declined by 22.45% to $6.46. The company's market cap stands at $422.2 million.
• Kewaunee Scientific (NASDAQ:KEQU) shares decreased by 21.48% to $28.01. The market value of their outstanding shares is at $79.9 million.
• Protagenic Therapeutics (NASDAQ:PTIX) stock declined by 20.64% to $0.31. The company's market cap stands at $2.2 million.
• Connect Biopharma Hldgs (NASDAQ:CNTB) stock fell 20.64% to $0.5. The company's market cap stands at $27.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.